Soyasaponin Bb

Soyasaponin Bb is an orally active, covalent inducer of heme oxygenase HO-1 and an inhibitor of aldose reductase AKR1B1. Soyasaponin Bb can regulate oxidative stress pathways, enhance antioxidant capacity, reduce reactive oxygen species (ROS) generation, and inhibit lipid peroxidation and hepatocyte apoptosis. Soyasaponin Bb improves alcohol-induced hepatocyte membrane damage and liver function abnormalities, and improves Scopolamine (HY-N0296)-induced memory impairment. Soyasaponin Bb has antioxidant, hepatoprotective, and neuroprotective activities^[1][2][3][4]. In Vitro:Soyasaponin Bb (25-100 μg/mL; pretreatment for 24 h + ethanol treatment for 24 h) increases cell viability, reduces reactive oxygen species (ROS) levels, increases superoxide dismutase (SOD) and glutathione (GSH) activities, downregulates malondialdehyde (MDA) and alanine aminotransferase (ALT) levels, and induces heme oxygenase-1 (HO-1) expression in rat hepatocyte BRL 3A assay^[1].
Soyasaponin Bb (2.36-94.30 mg/L; 4 h) shows no significant cytotoxicity in the Caco-2 intestinal epithelial cell experiment. Soyasaponin Bb has an apparent permeability (P_app) across the membrane of less than 1.0×10^-6 cm/s), with the apical-to-basolateral (AP-BL) transport significantly higher than the basolateral-to-apical (BL-AP) transport, indicating that the cell permeation of Soyasaponin Bb is mainly passive transport^[2]. In Vivo:Soyasaponin Bb (100 mg/kg; oral administration; single dose) showes a peak plasma drug concentration of 19.8 ng/mL in the Sprague-Dawley rat model. It was mainly excreted in the feces, with very little excretion in the urine. The metabolite Soyasapogenol B was only detected in the feces^[2].
Soyasaponin Bb (10 mg/kg; oral administration; once a day; for 5 consecutive days) significantly improves passive avoidance, Y-maze and Morris water maze task performance in the Scopolamine (HY-N0296)-induced mouse memory impairment model, increases brain-derived neurotrophic factor (BDNF) expression and cyclic adenosine monophosphate response element binding protein (CREB) phosphorylation level, without inhibiting acetylcholinesterase (AChE) activity^[3].